ArticleProceedings of the National Academy of Sciences of the United States of America2021

A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancer.

Lingfan Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.